Perforin 1 inhibitors are a category of chemical compounds that specifically target and modulate the activity of perforin 1, a crucial protein involved in immune responses. Perforin 1, also known as PRF1, is primarily found in cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, which are integral components of the immune system responsible for eliminating infected or cancerous cells. Perforin 1 plays a pivotal role in the host's defense mechanisms by creating pores or channels in the target cell's membrane. These pores allow for the entry of cytotoxic enzymes called granzymes into the target cell, initiating a cascade of events leading to cell death.
Perforin 1 inhibitors are designed to interfere with the function of perforin 1, either by blocking its synthesis or inhibiting its activity. These inhibitors work at the molecular level, disrupting the perforin 1-mediated cell-killing mechanism. By modulating the perforin 1 pathway, these compounds have the potential to influence the immune response in various ways, which can be explored for research purposes. Understanding how perforin 1 inhibitors impact immune cells and their cytotoxic activity can provide valuable insights into immunology and the development of novel strategies for immune modulation. Additionally, these inhibitors may have implications beyond immunology, as perforin 1 has been associated with certain autoimmune diseases, making this chemical class of interest for broader biomedical research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytosporone B | 321661-62-5 | sc-252653 | 5 mg | $146.00 | 7 | |
Cytosporone B inhibits perforin expression by modulating transcription factors, reducing the production of perforin by cytotoxic T cells. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A disrupts the acidification of cytotoxic granules, preventing perforin activation, and the release of cytotoxic granules. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose reduces energy production in cytotoxic T cells, impairing the release and function of perforin and other cytotoxic factors. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits the PI3-kinase pathway, disrupting intracellular signaling required for perforin secretion by cytotoxic T cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, similar to Wortmannin, inhibits the PI3-kinase pathway, interfering with perforin release by cytotoxic T lymphocytes. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound inhibits protein kinase C (PKC), which plays a role in perforin activation, reducing its cytotoxic potential. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A inhibits the Ras signaling pathway, disrupting the downstream events necessary for perforin secretion by T cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of T cell activation, leading to reduced perforin production and cytotoxicity. | ||||||